Sequoia Financial Advisors LLC Lowers Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sequoia Financial Advisors LLC reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 11.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,678 shares of the company’s stock after selling 1,146 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $678,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of PBH. Huntington National Bank boosted its stake in shares of Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after acquiring an additional 181 shares in the last quarter. Natixis Advisors LLC boosted its stake in shares of Prestige Consumer Healthcare by 11.4% during the 3rd quarter. Natixis Advisors LLC now owns 14,581 shares of the company’s stock worth $1,051,000 after acquiring an additional 1,491 shares in the last quarter. Quest Partners LLC boosted its stake in shares of Prestige Consumer Healthcare by 2,582.0% during the 3rd quarter. Quest Partners LLC now owns 11,774 shares of the company’s stock worth $849,000 after acquiring an additional 11,335 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter worth about $620,000. Finally, Eagle Asset Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 0.7% during the 3rd quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company’s stock worth $31,328,000 after acquiring an additional 3,227 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PBH has been the topic of several recent analyst reports. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a research note on Monday, December 9th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $92.60.

Prestige Consumer Healthcare Stock Up 1.4 %

PBH stock opened at $84.87 on Tuesday. The company has a market cap of $4.20 billion, a price-to-earnings ratio of 19.88, a PEG ratio of 2.69 and a beta of 0.46. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $90.04. The firm has a 50-day moving average of $81.67 and a two-hundred day moving average of $78.38.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.